Compare ODTX & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ODTX | LZB |
|---|---|---|
| Founded | 2021 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2025 | 1994 |
| Metric | ODTX | LZB |
|---|---|---|
| Price | $20.42 | $29.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $35.75 | ★ $41.00 |
| AVG Volume (30 Days) | 245.6K | ★ 629.9K |
| Earning Date | 11-12-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 3.27% |
| EPS Growth | N/A | ★ 5.11 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,349,433,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.10 | $28.92 |
| 52 Week High | $29.05 | $44.90 |
| Indicator | ODTX | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 48.10 | 29.02 |
| Support Level | $22.30 | N/A |
| Resistance Level | $28.53 | $36.50 |
| Average True Range (ATR) | 1.99 | 0.74 |
| MACD | -0.22 | 0.20 |
| Stochastic Oscillator | 50.43 | 8.60 |
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.
La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.